New hospital disinfection processes for both conventional and prion infectious agents compatible with thermosensitive medical equipment

Journal of Hospital Infection

Volumn 72, Issue 4, 2009, Pages 342-350

  Lehmann, S ^a,b   Pastore, M ^a   Rogez Kreuz, C ^c   Richard, M ^d   Belondrade, M ^a   Rauwel, G ^e   Durand, F ^e   Yousfi, R ^c   Criquelion, J ^e   Clayette, P ^c   Perret Liaudet, A ^d  

^a INSTITUTE OF HUMAN GENETICS   (France)

^b HÔPITAL SAINT ELOI   (France)

^c INSTITUT DE RADIOPROTECTION ET DE SÛRETÉ NUCLÉAIRE   (France)

^d HOSPICES CIVILS DE LYON   (France)

^e Laboratoires Anios   (France)

Author keywords

Copper; Creutzfeldt Jakob disease; Decontamination; Prion protein

Indexed keywords

COPPER; DETERGENT; HYDROGEN PEROXIDE; PERACETIC ACID; STEEL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN HOMOGENATE; CLINICAL EFFECTIVENESS; CONTAMINATION; CONTROLLED STUDY; DISINFECTION; EXPERIMENTAL MODEL; HAMSTER; HEAT SENSITIVITY; HOSPITAL CARE; HUMAN; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MEDICAL INSTRUMENTATION; NONHUMAN; PRION DISEASE; VIRUS PATHOGENESIS; VIRUS STRAIN;

ANIMALS; BACTERIA; COPPER; CRICETINAE; CROSS INFECTION; DISINFECTANTS; DISINFECTION; EQUIPMENT AND SUPPLIES, HOSPITAL; FUNGI; HUMANS; HYDROGEN PEROXIDE; MESOCRICETUS; MICE; PRION DISEASES; PRIONS; VIRUSES;

EID: 67651085292     PISSN: 01956701     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhin.2009.03.024     Document Type: Article

References (26)

1. Prusiner S.B., Scott M.R., Dearmond S.J., and Cohen F.E. Prion protein biology. Cell 93 (1998) 337-348
2. Wadsworth J.D., and Collinge J. Update on human prion disease. Biochim Biophys Acta 1772 (2007) 598-609
3. Will R.G., Ironside J.W., Zeidler M., et al. A new variant of Creutzfeldt-Jakob disease in the UK. Lancet 347 (1996) 921-925
4. Hilton D.A. Pathogenesis and prevalence of variant Creutzfeldt-Jakob disease. J Pathol 208 (2006) 134-141
5. Wadsworth J.D., Joiner S., Hill A.F., et al. Tissue distribution of protease resistant prion protein in variant Creutzfeldt-Jakob disease using a highly sensitive immunoblotting assay. Lancet 358 (2001) 171-180
6. Peden A.H., Ritchie D.L., Head M.W., and Ironside J.W. Detection and localization of PrPSc in the skeletal muscle of patients with variant, iatrogenic, and sporadic forms of Creutzfeldt-Jakob disease. Am J Pathol 168 (2006) 927-935
7. Brown P., Gibbs Jr. C.J., Rodgers-Johnson P., et al. Human spongiform encephalopathy: the National Institutes of Health series of 300 cases of experimentally transmitted disease. Ann Neurol 35 (1994) 513-529
8. WHO. Infection control guidelines for transmissible spongiform encephalopathies. Report 23-26 March 1999, WHO/CDS/CSR/APH/2000.3 (1999), WHO, Geneva
9. Taylor D.M. Inactivation of prions by physical and chemical means. J Hosp Infect 43 Suppl. (1999) S69-S76
10. Brown P., Rohwer R.G., and Gajdusek D.C. Sodium hydroxide decontamination of Creutzfeldt-Jakob disease virus. N Engl J Med 310 (1984) 727
11. Fichet G., Comoy E., Duval C., et al. Novel methods for disinfection of prion-contaminated medical devices. Lancet 364 (2004) 521-526
12. Jackson G.S., McKintosh E., Flechsig E., et al. An enzyme-detergent method for effective prion decontamination of surgical steel. J Gen Virol 86 (2005) 869-878
13. Peretz D., Supattapone S., Giles K., et al. Inactivation of prions by acidic sodium dodecyl sulfate. J Virol 80 (2006) 322-331
14. Lemmer K., Mielke M., Pauli G., and Beekes M. Decontamination of surgical instruments from prion proteins: in vitro studies on the detachment, destabilization and degradation of PrPSc bound to steel surfaces. J Gen Virol 85 (2004) 3805-3816
15. Baier M., Schwarz A., and Mielke M. Activity of an alkaline 'cleaner' in the inactivation of the scrapie agent. J Hosp Infect 57 (2004) 80-84
16. Taylor D.M. Resistance of the ME7 scrapie agent to peracetic acid. Vet Microbiol 27 (1991) 19-24
17. Brown D.R., Qin K., Herms J.W., et al. The cellular prion protein binds copper in vivo. Nature 390 (1997) 684-687
18. Lehmann S. Metal ions and prion diseases. Curr Opin Chem Biol 6 (2002) 187-192
19. McMahon H.E., Mange A., Nishida N., Creminon C., Casanova D., and Lehmann S. Cleavage of the amino-terminus of the prion protein by reactive oxygen species. J Biol Chem 276 (2001) 2286-2291
20. Solassol J., Pastore M., Crozet C., Perrier V., and Lehmann S. A novel copper-hydrogen peroxide formulation for prion decontamination. J Infect Dis 194 (2006) 865-869
21. Zobeley E., Flechsig E., Cozzio A., Enari M., and Weissmann C. Infectivity of scrapie prions bound to a stainless steel surface. Mol Med 5 (1999) 240-243
22. Bach S., Talarek N., Andrieu T., et al. Isolation of drugs active against mammalian prions using a yeast-based screening assay. Nat Biotechnol 21 (2003) 1075-1081
23. Solassol J., Arlotto M., and Lehmann S. Detection of prion after decontamination procedures: comparative study of standard western blot, filter retention and scrapie-cell assay. J Hosp Infect 57 (2004) 156-161
24. Kärber G. Beitrag zur kollektiven Behandlung pharmakologischer Reihenversuche. Arch Exp Pathol Pharmakol 162 (1931) 956-959
25. Wadsworth J.D., Hill A.F., Joiner S., Jackson G.S., Clarke A.R., and Collinge J. Strain-specific prion-protein conformation determined by metal ions. Nat Cell Biol 1 (1999) 55-59
26. Taylor D.M. Inactivation of transmissible degenerative encephalopathy agents: a review. Vet J 159 (2000) 10-17